Vai al contenuto principale della pagina

Transmucosal Absorption Enhancers in the Drug Delivery Field



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Maher Sam Visualizza persona
Titolo: Transmucosal Absorption Enhancers in the Drug Delivery Field Visualizza cluster
Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica: 1 electronic resource (406 p.)
Soggetto non controllato: chitosan
intestinal epithelial cells
ocular delivery
amphiphilic polymers
cornea
tight junction modulator
cyclodextrin
permeability
gemini surfactant
transferrin
compound 48/80
epithelial permeability
cervicovaginal tumors
nanoparticles
confocal laser scanning microscopy
safety
formulation
salcaprozate sodium
intestinal absorption
FITC-dextran
curcumin
block copolymers
nasal vaccination
whole leaf
brush border
ocular drug delivery
vaccine adjuvant
nanoparticle
nasal delivery
efflux
permeation enhancers
absorption enhancers
nose to brain delivery
small intestine
epithelium
CNS disorders
absorption modifying excipients
insulin
absorption enhancer
gel
intestinal delivery
thermogel system
Caco-2
biocompatibility studies
absorption enhancement
man
PN159
poorly absorbed drug
tryptophan
tight junction
oral macromolecule delivery
penetration enhancer
intestinal permeation enhancers
nanocrystals
simvastatin
nanomedicine
enterocyte
N-dodecyl-?-D-maltoside (DDM)
cell-penetrating peptide
quaternization
KLAL
nasal
nasal permeability
transmucosal drug delivery
Caco-2 cells
mast cell activator
penetration enhancers
drug delivery
nose-to-brain
bioenhancer
polymeric micelles
mucoadhesion
cell-penetrating peptide (CPP)
simulated intestinal fluid
vaginal delivery
nasal formulation
pharmacokinetic interaction
sodium caprate
clinical trial
transmucosal permeation
drug absorption enhancer
sugar-based surfactants
nanocapsules
imatinib
teriparatide
osteoporosis
hydrophobization
F-actin
combined microsphere
transepithelial electrical resistance
oral delivery
ocular conditions
metabolism
antimicrobial peptide
permeation enhancer
drug administration
antiepileptic drug
amino acid
in vivo studies
sodium cholate (NaC)
epithelial transport
preclinical
nose to brain transport
pharmacokinetics
chitosan derivatives
ophthalmology
tight junctions
sheep
cationic functionalization
GLP-1
pulmonary
and liposome
cytochrome P450
claudin
P-glycoprotein
in situ hydrogel
mucoadhesiveness
PTH 1-34
Aloe vera
oral peptides
Persona (resp. second.): IllumLisbeth
CasettariLuca
Sommario/riassunto: Development of strategies to assist the movement of poorly permeable molecules across biological barriers has long been the goal of drug delivery science. In the last three decades, there has been an exponential increase in advanced drug delivery systems that aim to address this issue. However, most proprietary delivery technologies that have progressed to clinical development are based on permeation enhancers (PEs) that have a history of safe use in man. This Special Issue entitled “Transmucosal Absorption Enhancers in the Drug Delivery Field” aims to present the current state-of-the-art in the application of PEs to improve drug absorption. Emphasis is placed on identification of novel permeation enhancers, mechanisms of barrier alteration, physicochemical properties of PEs that contribute to optimal enhancement action, new delivery models to assess PEs, studies assessing safety of PEs, approaches to assist translation of PEs into effective oral, nasal, ocular and vaginal dosage forms and combining PEs with other delivery strategies.
Titolo autorizzato: Transmucosal Absorption Enhancers in the Drug Delivery Field  Visualizza cluster
ISBN: 3-03921-849-2
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910372785603321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui